Comparison to Psychological, Medical and Emotional Influencing Communication and Achievement Factors to Oncogenetics Tests

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-08-31

Study Completion Date

2018-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study was to analyze the psychological and emotional determinants of domestic dissemination of information about genetic risk of cancer and to compare the level of diffusion syndromes in breast/ ovarian cancer ( BRCA1 / BRCA2) and colon/endometrial ( HNPCC )

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessment Psychological Distress for Cancer Heredity Test

NCT04428710

Cancer Psychological Distress Hereditary Diseases +1 more

UNKNOWN

Facilitating Oncology Patient-Clinician Communication Via E-health Innovations

NCT03442127

Breast Cancer

COMPLETED NA

Educational Intervention to Increase the Emotional Competence of Patients With Oesogastric and Bronchopulmonary Cancers

NCT03306693

Digestive System Neoplasms Thoracic Neoplasms

TERMINATED NA

Breast Cancer and Resilience in Couple

NCT06875414

Breast Neoplasms Quality of Life

RECRUITING

Access to Genetic Testing in Underserved Patients With Cancer

NCT06422455

Breast Carcinoma Male Breast Carcinoma Malignant Solid Neoplasm +5 more

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The risk associated with a genetic predisposition is among the various forms of risk, the strongest identifiable risk . It enables to offer people at risk an appropriate medical care (screening, prevention ) the clinical benefit is validated today. The person with whom a predisposing mutation has been identified must communicated its related information on the risk of cancer and the ability to perform genetic analysis. It appears that this dissemination of information is not always optimal, as shown in figures from the National Cancer Institute joined the project; the purpose of the study was to analyze the psychological and emotional determinants of domestic dissemination of information about genetic risk of cancer and to compare the level of diffusion syndromes in breast/ ovarian cancer ( BRCA1 / BRCA2) and colon/endometrial ( HNPCC )

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Colorectal Cancer Breast Cancer Ovarian Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Behaviour

Comparison to psychological, medical and emotional Influencing communication and achievement factors to Oncogenetics tests

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient having a deleterious genetic mutation on genes BRCA1 and/or BRCA2 and or on genes MMR
* The patient being of the family (who carried out a full analysis of BRCA1/BRCA2 and/or those MMR )

Exclusion Criteria

* Patient not carrying a deleterious genetic mutation on the BRCA1/2 genes and/or those of the MMR system,
* Patient under guardianship, curator or unable to give his non-opposition,
* Adult patients protected by law.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No